Most Read Articles
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
6 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Pearl Toh, 3 days ago
A latest study at ISC 2019 shows that even patients with large-core stroke damage can have a good outcome after mechanical clot removal with endovascular thrombectomy (EVT), depending on the size of the infarct and time lapses between stroke onset and treatment.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

Lifestyle interventions effective against nonobese NAFLD patients

06 Dec 2018

Lifestyle interventions appear to effectively induce remission of nonalcoholic fatty liver disease (NAFLD) in both obese and nonobese patients, reports a new study.

The study included 154 NAFLD patients who were randomly assigned to receive usual care (n=77) or a 12-month lifestyle intervention programme and regular exercise (n=77). In each group, 39 and 38 patients had body mass index (BMI) <25 and 25 kg/m2, respectively. Proton-magnetic resonance spectroscopy was used to assess the primary outcome of NAFLD remission.

Significantly more patients with BMI <25 kg/m2 who received the intervention vs usual care had NAFLD remission at 12 months (67 percent vs 18 percent; p<0.001). In the respective groups, the mean decline in intrahepatic triglyceride content (IHTG) was 6.1 percent and 1.3 percent, the difference between which was statistically significant (p=0.001).

In patients with BMI 25 kg/m2, 61 percent of those who received the lifestyle intervention programme achieved NAFLD remission. This effect was significantly greater than that from usual care (21 percent; p<0.001). The resulting mean reductions in IHTG were 7.4 percent and 2.9 percent, respectively (p=0.004).

The effects of lifestyle intervention also appeared sustainable. A the 6-year follow-up, significantly more participants who received the exercise intervention vs controls had BMI lower than baseline (19.1 percent vs 8.6 percent; p=0.037).

Moreover, although rebound in body weight was observed after termination of the intervention, the mean change in body weight at year 6 was significantly more pronounced in the intervention vs control group (–1.9±4.7 vs 0.4±3.3 kg; p=0.0022).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
6 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Pearl Toh, 3 days ago
A latest study at ISC 2019 shows that even patients with large-core stroke damage can have a good outcome after mechanical clot removal with endovascular thrombectomy (EVT), depending on the size of the infarct and time lapses between stroke onset and treatment.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.